---  
layout: startup_page  
title: "Vicebio"  
id: "vicebio.com"  
permalink: "/vicebiovicebio.com09232024/"  
website: "https://www.vicebio.com"  
funding_round: "Series B"  
funding_amount: "$100M"  
investors: "TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio, UniQuest, Medicxi"  
about: "Vicebio Ltd is a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections using its proprietary Molecular Clamp technology. This technology stabilizes viral glycoproteins, enabling the production of highly effective and easy-to-manufacture vaccines. The company is currently conducting a Phase I clinical trial for a bivalent vaccine targeting RSV and hMPV."  
markets: "Biotechnology, Vaccines, Pharmaceuticals, Medical"  
hq: "London, England, United Kingdom"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/vicebio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/vicebio"  
pitchbook: "https://pitchbook.com/profiles/company/472283-47"  

date_display: "23-Sep-2024"  
date: "2024-09-23"

# SEO Optimization  
meta_title: "Vicebio - Series B Funding ($100M)"  
meta_description: "Vicebio, Vicebio Ltd is a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections using its proprietary Molec..."  
meta_keywords: "Vicebio, Biotechnology, Vaccines, Pharmaceuticals, Medical, Series B funding"  
canonical_url: "https://startup.projectstartups.com/vicebiovicebio.com09232024/"  
---